Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA)
TOETVA
1 other identifier
interventional
60
1 country
1
Brief Summary
Prospective study carried out with ICESP (instituto do Câncer do Estado de São Paulo) patients with thyroid disease with surgical indication
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2022
CompletedStudy Start
First participant enrolled
May 25, 2022
CompletedFirst Posted
Study publicly available on registry
June 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMay 14, 2024
March 1, 2024
2.6 years
May 18, 2022
May 12, 2024
Conditions
Outcome Measures
Primary Outcomes (8)
To compare TOETVA technique with conventional thyroidectomy in terms of operative time
Operative time will be measured by minutes
1 year
To compare TOETVA technique with conventional thyroidectomy in terms of post operative surgical complications, such as laryngeal nerve dysfunction
This outcome will be accessed by performing laryngoscopy before and after the surgery
1 year
To compare TOETVA technique with conventional thyroidectomy in terms of post operative surgical complications, such as hypoparathyroidism
This outcome will be accessed by accessing de blood calcium and parathormone levels after the surgery
1 year
To compare TOETVA technique with conventional thyroidectomy in terms of post operative surgical complications, such as hematoma formation
This outcome will be accessed by qualitative analysis
1 year
To compare TOETVA technique with conventional thyroidectomy in terms of post operative surgical complications, such as seroma formation
This outcome will be accessed by qualitative analysis
1 year
To compare TOETVA technique with conventional thyroidectomy in terms of post operative surgical complications, such as skin injury
This outcome will be accessed by qualitative analysis
1 year
To compare TOETVA technique with conventional thyroidectomy in terms of post operative pain
This outcome will be accessed by visual pain scale from grade 1 (better) to 10 (worse)
1 year
To compare TOETVA technique with conventional thyroidectomy in terms of time of hospitalization
This outcome will be accessed by number of days spent in the hospital
1 year
Secondary Outcomes (3)
Comparison on quality of life - questionnaire 1.
1 year
Comparison on quality of life - questionnaire 2.
1 year
Comparison on quality of life - questionnaire 3.
1 year
Study Arms (2)
TOETVA
ACTIVE COMPARATORPatients submitted to transoral endoscopic thyroidectomy by vestibular approach
CONVENTIONAL THYROIDECTOMY
ACTIVE COMPARATORPatients submitted to conventional open thyroidectomy by cervical approach
Interventions
conventional open thyroidectomy by cervical approach
Eligibility Criteria
You may qualify if:
- history of hypertrophic scarring and/or motivation to avoid cervical scarring,
- maximum diameter of the thyroid \< 10 cm and of the dominant nodule \< 6 cm,
- estimated thyroid volume \< 45 ml
- benign lesion (multinodular goiter, cyst),
- indeterminate nodule (Bethesda III or IV),
- suspicious nodule for well-differentiated thyroid carcinoma (Bethesda V and VI) \< 2 cm
You may not qualify if:
- history of previous surgery or irradiation in the head and neck region and superior mediastinum
- evidence of clinical hyperthyroidism
- preoperative recurrent nerve palsy
- lymph node metastasis
- extra-thyroid extension
- plunging goiter
- oral abscess
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ICESP
São Paulo, São Paulo, 01246000, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fabio Capelli, phd
Instituto do Cancer do Estado de São Paulo
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 18, 2022
First Posted
June 9, 2022
Study Start
May 25, 2022
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
May 14, 2024
Record last verified: 2024-03